A&M Could Be In Running To Mass-Produce Treatment
Stephanie Cannon '06 August 11, 2014 9:02 AM
There's no standardized treatment for the Ebola virus, but Texas A&M could play a key role in producing one.
The two Americans with Ebola have been given an experimental drug and are improving. Nancy Writebol left Liberia for the U.S. Monday night. Dr. Kent Brantly arrived at Emory University Hospital in Atlanta over the weekend.
If the treatment is successful, it could be mass-produced at the Texas A&M Center for Innovation in Advanced Development and Manufacturing, one of three places in the country able to standardize a treatment for a virus such as Ebola, said Scott Lillibridge, assistant dean and professor at the Texas A&M Health Science Center School of Public Health.
Read more at theeagle.com.
The two Americans with Ebola have been given an experimental drug and are improving. Nancy Writebol left Liberia for the U.S. Monday night. Dr. Kent Brantly arrived at Emory University Hospital in Atlanta over the weekend.
If the treatment is successful, it could be mass-produced at the Texas A&M Center for Innovation in Advanced Development and Manufacturing, one of three places in the country able to standardize a treatment for a virus such as Ebola, said Scott Lillibridge, assistant dean and professor at the Texas A&M Health Science Center School of Public Health.
Read more at theeagle.com.
505 George Bush Drive
College Station, TX 77840
(979) 845-7514
When Aggies see a need, their energy and their selflessness draw others into the cause, and good things happen.
© 2024 The Association of Former Students of Texas A&M University, All Rights Reserved